Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Ionis Pharmaceuticals
Biotech
Biogen walks away from Ionis-partnered ALS, Angelman prospects
Biogen’s CEO may have been celebrating “turning a corner” last month, but it looks like the drugmaker’s early-stage pipeline hasn’t got the message
James Waldron
May 16, 2024 9:24am
Arrowhead on target in lipid disorder as it pursues Ionis
Apr 8, 2024 9:37am
Ionis raises hand in MASH race, shows liver gains in ph. 2 test
Mar 13, 2024 9:54am
Ionis’ HAE drug wins in phase 3 setting up approval run to FDA
Jan 22, 2024 9:34am
Otsuka pays Ionis $65M for European rights to rare disease drug
Dec 19, 2023 10:18am
AstraZeneca adds Latin America to Ionis ATTR deal for $20M
Jul 28, 2023 10:05am